FDA: New Email List on HIV/AIDS.The U.S. Food and Drug Administration has started an email list anyone can join, to provide AIDS-related information from the Agency. The official announcement, below, gives details. Note: The sign-up process shows users confusing options -- but they can be ignored. Just stay with the defaults provided, unless you know you want something else. "An e-mail list has been established by the Division of Antiviral Drug antiviral drug, any of several drugs used to treat viral infections. The drugs act by interfering with a virus's ability to enter a host cell and replicate itself with the host cell's DNA. Products (Center for Drug Evaluation and Research The Center for Drug Evaluation and Research is a division of the FDA that deals with the approval of drugs. CDER reviews New Drug Applications to ensure that the drugs are safe and effective. It is one of five Centers at the United States Food and Drug Administration. ) and the Office of Special Health Issues (Office of the Commissioner) of the Food and Drug Administration (FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. ) to provide updates on safety and regulatory issues related to HIV/AIDS HIV/AIDS Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome products. "The purpose of this e-mail list is to give patients, industry, academia, other government agencies and other interested parties one source for FDA HIV/AIDS related information. Information such as product approvals, significant labeling changes, safety warnings, notices of upcoming public meetings and alerts to proposed regulatory guidances for comment will be distributed through this e-mail list. "To join the e-mail list, please go to [less than]http://list.nih.gov/archives/fda-hiv-aids.html[greater than]. Your name and e-mail address See Internet address. e-mail address - electronic mail address is considered confidential and will not be released. "If you are interested in regulatory guidance and requirements for blood safety, you should also register for the FDA's Center for Biologics Evaluation and Research The Center for Biologics Evaluation and Research (CBER) is one of six main centers for the Food and Drug Administration, which is in the United States Department of Health and Human Services. e-mail list at http://www.fda.gov/cber/pubinfo/elists.htm. "The HIV/AIDS e-mail list is not intended or designed to accept comments or input, but merely to disseminate important HIV/AIDS-related information and alert interested parties about HIV/AIDS related issues for public comment. "Information will be distributed through this e-mail list as it becomes available, rather than on a regularly scheduled basis. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion